Chaojun Xi1, Fengri Li2, Wuzhong Cheng3, Shaoxia Wang1, Rong Zhang4, Yaping Wang2, Lili Liu2. 1. Department of Critical Care Medicine, Shanghai Construction Group (SCG) Hospital Hongkou, Shanghai 200083, China. 2. Department of Pain, Shanghai Quyang Hospital Hongkou, Shanghai 200092, China. 3. Beijing Hospital of Traditional Chinese Medicine, Capital Medical University Dongcheng, Beijing 100010, China. 4. General Affairs Section, Yangpu Hospital of Traditional Chinese Medicine Shanghai 200090, China.
Abstract
OBJECTIVE: This study evaluated the efficacy of traditional Chinese and western medicine combined with chronic disease management on rehabilitation of chronic obstructive pulmonary disease (COPD) patients. METHODS: A total of 199 COPD patients in Shanghai Construction Group (SCG) Hospital were recruited as research objects. The control group (CG) consisted of 100 patients treated with conventional western chronic disease management, and the research group (RG) consisted of 99 patients treated with chronic disease management with combined traditional Chinese and western medicine. The efficacy, pulmonary rehabilitation performance, compliance score, 6-minute walk test (6MWT), modified Medical Research Council dyspnoea scale (MMRC), COPD assessment test (CAT), pulmonary function (PaO2, PaCO2, FEV1, PEF), self-rating anxiety scale (SAS), self-rating depression scale (SDS) and patient satisfaction between the two groups were compared. RESULTS: Pulmonary rehabilitation performance, 6MWT results, and patient satisfaction in the RG were significantly better than those in the CG. The total effective rate, compliance score, PaO2, FEV1 and PEF of the RG were significantly higher than those of the CG. After treatment, the COPD symptom score, CAT score, PaCO2, SAS score and SDS score in the RG were significantly lower than those in the CG. CONCLUSION: Chronic disease management with combined traditional Chinese and western medicine has great application value and high efficacy in pulmonary rehabilitation. AJTR
OBJECTIVE: This study evaluated the efficacy of traditional Chinese and western medicine combined with chronic disease management on rehabilitation of chronic obstructive pulmonary disease (COPD) patients. METHODS: A total of 199 COPDpatients in Shanghai Construction Group (SCG) Hospital were recruited as research objects. The control group (CG) consisted of 100 patients treated with conventional western chronic disease management, and the research group (RG) consisted of 99 patients treated with chronic disease management with combined traditional Chinese and western medicine. The efficacy, pulmonary rehabilitation performance, compliance score, 6-minute walk test (6MWT), modified Medical Research Council dyspnoea scale (MMRC), COPD assessment test (CAT), pulmonary function (PaO2, PaCO2, FEV1, PEF), self-rating anxiety scale (SAS), self-rating depression scale (SDS) and patient satisfaction between the two groups were compared. RESULTS: Pulmonary rehabilitation performance, 6MWT results, and patient satisfaction in the RG were significantly better than those in the CG. The total effective rate, compliance score, PaO2, FEV1 and PEF of the RG were significantly higher than those of the CG. After treatment, the COPD symptom score, CAT score, PaCO2, SAS score and SDS score in the RG were significantly lower than those in the CG. CONCLUSION:Chronic disease management with combined traditional Chinese and western medicine has great application value and high efficacy in pulmonary rehabilitation. AJTR
Authors: Ji Wen; Xi-Sheng Xie; Ming-Hua Zhang; Nan Mao; Cheng-Long Zhang; Lin-Shen Xie; Yuan Cheng; Zi-Yuan Zhang; Jun-Ming Fan Journal: Sichuan Da Xue Xue Bao Yi Xue Ban Date: 2014-01
Authors: Jung Yeon Lee; Gyu Rak Chon; Chin Kook Rhee; Deog Kyeom Kim; Hyoung Kyu Yoon; Jin Hwa Lee; Kwang Ha Yoo; Sang Haak Lee; Sang Yeub Lee; Tae-Eun Kim; Tae-Hyung Kim; Yong Bum Park; Yong Il Hwang; Young Sam Kim; Ki Suck Jung Journal: J Korean Med Sci Date: 2016-03-10 Impact factor: 2.153
Authors: Katherine E Lowe; Elizabeth A Regan; Antonio Anzueto; Erin Austin; John H M Austin; Terri H Beaty; Panayiotis V Benos; Christopher J Benway; Surya P Bhatt; Eugene R Bleecker; Sandeep Bodduluri; Jessica Bon; Aladin M Boriek; Adel Re Boueiz; Russell P Bowler; Matthew Budoff; Richard Casaburi; Peter J Castaldi; Jean-Paul Charbonnier; Michael H Cho; Alejandro Comellas; Douglas Conrad; Corinne Costa Davis; Gerard J Criner; Douglas Curran-Everett; Jeffrey L Curtis; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Jennifer G Dy; Ashraf Fawzy; Margaret Fleming; Eric L Flenaugh; Marilyn G Foreman; Spyridon Fortis; Hirut Gebrekristos; Sarah Grant; Philippe A Grenier; Tian Gu; Abhya Gupta; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Lystra P Hayden; Craig P Hersh; Brian D Hobbs; Eric A Hoffman; James C Hogg; John E Hokanson; Karin F Hoth; Albert Hsiao; Stephen Humphries; Kathleen Jacobs; Francine L Jacobson; Ella A Kazerooni; Victor Kim; Woo Jin Kim; Gregory L Kinney; Harald Koegler; Sharon M Lutz; David A Lynch; Neil R MacIntye; Barry J Make; Nathaniel Marchetti; Fernando J Martinez; Diego J Maselli; Anne M Mathews; Meredith C McCormack; Merry-Lynn N McDonald; Charlene E McEvoy; Matthew Moll; Sarah S Molye; Susan Murray; Hrudaya Nath; John D Newell; Mariaelena Occhipinti; Matteo Paoletti; Trisha Parekh; Massimo Pistolesi; Katherine A Pratte; Nirupama Putcha; Margaret Ragland; Joseph M Reinhardt; Stephen I Rennard; Richard A Rosiello; James C Ross; Harry B Rossiter; Ingo Ruczinski; Raul San Jose Estepar; Frank C Sciurba; Jessica C Sieren; Harjinder Singh; Xavier Soler; Robert M Steiner; Matthew J Strand; William W Stringer; Ruth Tal-Singer; Byron Thomashow; Gonzalo Vegas Sánchez-Ferrero; John W Walsh; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Gloria Westney; Ava Wilson; Robert A Wise; Andrew Yen; Kendra Young; Jeong Yun; Edwin K Silverman; James D Crapo Journal: Chronic Obstr Pulm Dis Date: 2019-11